Recursion grants director Hassan 156,658 stock units

One-third of the award vests on each of the first three anniversaries of November 2, 2026, subject to continued service.

Available on EDGAR 11/04/2026 - 05:13 PM EST Accepted by SEC EDGAR 11/04/2026 - 05:12 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Recursion Pharmaceuticals (RXRX) director Fred Hassan received an automatic grant of 156,658 restricted stock units under the company’s Outside Director Compensation Policy on November 2, 2026. One-third of the award vests on each of the first three anniversaries of that date, subject to Hassan continuing to be a service provider through the applicable vesting dates.

Insider Trade Summary

Grant/Award: 156,658 shares

Grant/Award 1 txn

Insider Hassan Fred

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1	156,658	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 156,658 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.

Key Figures

Restricted stock unit award: 156,658 restricted stock units Vesting installment: 1/3rd of the shares subject to the award Vesting schedule: First three anniversaries

3 metrics

Restricted stock unit award 156,658 restricted stock units Granted November 2, 2026

Vesting installment 1/3rd of the shares subject to the award Vests on each applicable anniversary

Vesting schedule First three anniversaries Anniversaries of November 2, 2026

Key Terms

restricted stock units, Outside Director Compensation Policy, vest

3 terms

restricted stock units financial

"grant of restricted stock units automatically granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Outside Director Compensation Policy financial

"pursuant to Recursion’s Outside Director Compensation Policy"

vest financial

"will vest as to 1/3rd of the shares"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RXRX restricted stock units did director Fred Hassan receive?

Fred Hassan received an automatic grant of 156,658 restricted stock units under Recursion’s Outside Director Compensation Policy on November 2, 2026.

When do Fred Hassan’s RXRX restricted stock units vest?

One-third of the award vests on each of the first three anniversaries of November 2, 2026, subject to Fred Hassan continuing to be a service provider through each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hassan Fred

(Last) (First) (Middle)

41 S. RIO GRANDE ST.

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/02/2026		A		156,658	A(1)	$0	156,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.

Remarks:

	/s/ Kyle Nelson, attorney-in-fact	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)